EUDA Health Holdings Limited (NASDAQ:EUDA – Get Free Report) was the target of a large drop in short interest in September. As of September 30th, there was short interest totaling 641 shares, a drop of 59.7% from the September 15th total of 1,589 shares. Based on an average trading volume of 19,724 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of EUDA Health in a research report on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, EUDA Health currently has a consensus rating of “Hold” and a consensus price target of $55.00.
Read Our Latest Report on EUDA
EUDA Health Price Performance
EUDA Health (NASDAQ:EUDA – Get Free Report) last issued its earnings results on Tuesday, September 29th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of $0.40 by ($0.57). The firm had revenue of $1.73 million for the quarter, compared to analyst estimates of $9.61 million.
EUDA Health Company Profile
EUDA Health Holdings Limited is a healthcare technology company focused on providing digital and technology-enabled healthcare services. Through its platform and affiliated healthcare operations, the company aims to connect patients with medical professionals and make healthcare services more accessible through digital channels.
Its activities include telehealth and online medical consultations, healthcare information and patient-management services, and related wellness and medical support offerings.
Read More
- Five stocks we like better than EUDA Health
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
- IonQ Fell 9% on a $1.3 Billion Deal—Is Wall Street Missing Something?
Receive News & Ratings for EUDA Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EUDA Health and related companies with MarketBeat.com's FREE daily email newsletter.
